$OPGN I think I’ll vote NO to proposal 2. If they cannot make money from the china deal or sale in US after the FDA approval, they’re a lousy management team. China deal will be soon and FDA will be by end of Aug, and their 49M$ is enough for two years. They should cut down their CEO bonuses and do some real work instead of diluting our shares.
4
12
12 Likes